APOB and metabolic dysfunction-associated steatotic liver disease: Individual lipoprotein parameters such as increased small LDL, small HDL, and ApoB100 have been associated with increased atherogenic risk and diabetes independent of obesity, but less is known about lipoprotein characteristics relative to NAFLD progression [28, 29, 34–36].